Stryker's 8% CAGR revenue growth over the past 12 years was driven by organic growth and acquisitions. Learn more about SYK ...

Here are eight key developments from spine and orthopedic devicemakers since Oct. 9. 1. Johnson & Johnson MedTech began the ...

"Make sure that when you build your products, you're thinking about it as an open platform," Nvidia's Mostafa Toloui said ...

Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...

Canada’s device agency plans to issue guidance on machine learning, and the FDA plans to release a draft guidance next year on lifecycle management and premarket submissions for AI devices.

TORONTO—NYU Langone Health has tapped Philips to help take its pathology program fully digital—including translating its ...

Q3 2024 Earnings Call Transcript October 15, 2024 Johnson & Johnson beats earnings expectations. Reported EPS is $2.42, ...

Abbott Laboratories raised its 2024 earnings guidance after strong Q3 results, driven by growth in Pharma and MedTech ...

Focus on international early-stage and pre-commercial biotech & medtech opportunities ...

Nodenza Venture Partners launched - focus on international early-stage and pre-commercial ...

It has been nearly a week since former Commerce Minister Amin Modad resigned following controversy over the use of funds to purchase a luxury vehicle, which sparked public outrage and ultimately led ...